1673-5269
2010 Issue 13
..............page:1043
..............page:1043
Anti-tumor metastatic effects of inactivated allogeneic leukocytes infusion
SU Xiao-san;ZHANG Lei;WU Shang-min;YE Jun-song;CHEN Rui;GUAN Zheng First People’s Hospital of Kunming;Kunming 650011;P.R.China
SU Xiao-san;ZHANG Lei;WU Shang-min;YE Jun-song;CHEN Rui;GUAN Zheng First People’s Hospital of Kunming;Kunming 650011;P.R.China
..............page:991-994
Suboccipito-retrosigmoidal keyhole approach for microsurgical resection of acoustic neurinoma
HUANG Kuan-ming;MA Lian-ting;XU Guo-zheng;QIN Shang-zhen;YANG Ming;LI Jun Department of Neurosurgery;Wuhan General Hospital of Guangzhou Military Command;Wuhan 430070;P.R.China
HUANG Kuan-ming;MA Lian-ting;XU Guo-zheng;QIN Shang-zhen;YANG Ming;LI Jun Department of Neurosurgery;Wuhan General Hospital of Guangzhou Military Command;Wuhan 430070;P.R.China
..............page:1028-1030
Survival analysis of low-grade glioma treated by postoperative radiotherapy
LI Rong1;LAN Sheng-min2;WANG Hong-wei2;CAO Jian-zhong2;REN Shu-hui2;LUO Ning2;ZHANG Lei11.Graduate School;Shanxi Medical University;Taiyuan 030001;P.R.China2.Radiotherapy Center;Shanxi Tumor Hospital;Taiyuan 030013;P.R.China
LI Rong1;LAN Sheng-min2;WANG Hong-wei2;CAO Jian-zhong2;REN Shu-hui2;LUO Ning2;ZHANG Lei11.Graduate School;Shanxi Medical University;Taiyuan 030001;P.R.China2.Radiotherapy Center;Shanxi Tumor Hospital;Taiyuan 030013;P.R.China
..............page:1021-1024
Clinical pathology retrospective analysis of 1150 female cases of breast cancer in Suzhou City
XIAO Jian-jun1;TAO Min2;DUAN Wei-ming2;ZHOU Jing3;HU Yi-he31.Department of Oncology;Shaoxing Second Hospital;Shaoxing 312000;P.R.China2.Department of Oncology;First Affiliated Hospital of Soochow University;Suzhou 215000;P.R.China3.Center for Disease Control and Prevention of Suzhou;Suzhou 215000;P.R.China
XIAO Jian-jun1;TAO Min2;DUAN Wei-ming2;ZHOU Jing3;HU Yi-he31.Department of Oncology;Shaoxing Second Hospital;Shaoxing 312000;P.R.China2.Department of Oncology;First Affiliated Hospital of Soochow University;Suzhou 215000;P.R.China3.Center for Disease Control and Prevention of Suzhou;Suzhou 215000;P.R.China
..............page:995-999
Evaluation of bone metastasis characteristics of primary breast cancer with ~(99)Tc~m-MDP whole body bone imaging
WANG Chang-yin Department of Nuclear Medicine;Zhongnan Hospital;Wuhan University;Wuhan 430071;P.R.China
WANG Chang-yin Department of Nuclear Medicine;Zhongnan Hospital;Wuhan University;Wuhan 430071;P.R.China
..............page:1015-1017
yuan fa xing shi guan xiao xi bao ai yi li bao gao bing wen xian fu xi
hu qin cheng jing ji zhao ning
hu qin cheng jing ji zhao ning
..............page:1039-1040
Biodistribution of ~(32)P-chromicphosphate-poly L-lactic acid seeds after implantation in models and their potential impact on immune function
GAO Hai-lin;LIU Lu;YANG Ze-xuan;WU Qing-hua;HUANG Pei-lin;HUANG Ying Institute of Nuclear Medicine;Southeast University;Nanjing 210009;P.R.China
GAO Hai-lin;LIU Lu;YANG Ze-xuan;WU Qing-hua;HUANG Pei-lin;HUANG Ying Institute of Nuclear Medicine;Southeast University;Nanjing 210009;P.R.China
..............page:967-971
Analysis and cloning of human carboxypetidase A1 active fragment applicated in ADEPT
ZHENG Pei-chan;MA Yue-yun;LU Xue-tao;YUE Qiao-hong;ZHOU Shan;WANG Li-hua;GUO Xu-guang;ZENG Xian-fei;HAO Xiao-ke Department of Clinical Laboratory;Xijing Hospital;Fourth Military Medical University;Xi’an 710032;P.R.China
ZHENG Pei-chan;MA Yue-yun;LU Xue-tao;YUE Qiao-hong;ZHOU Shan;WANG Li-hua;GUO Xu-guang;ZENG Xian-fei;HAO Xiao-ke Department of Clinical Laboratory;Xijing Hospital;Fourth Military Medical University;Xi’an 710032;P.R.China
..............page:986-990
Clinical study of oxaliplatin combined with intensity modulation radiotherapy in treatment of local advanced nasopharyngeal carcinoma
SHEN Ze-tian;WU Xin-hu;LI Bing;WANG Lei;ZHU Xi-xuDepartment of Radiation Oncology;Nanjing General Hospital of Nanjing Military Command;Nanjing 210002;P.R.China
SHEN Ze-tian;WU Xin-hu;LI Bing;WANG Lei;ZHU Xi-xuDepartment of Radiation Oncology;Nanjing General Hospital of Nanjing Military Command;Nanjing 210002;P.R.China
..............page:1018-1020,1024
Clinical and imaging manifestations PNET in vertebral column
HONG Guo-bin1;2;WU Wei-ming1;CHEN Kai1;FENG Xiao-xin1;LIANG Bi-ling21.Department of Radiology;Fifth Affiliated Hospital;SUN Yat-sen University;Zhuhai 519000;P.R.China2.Department of Radiology;Second Affiliated Hospital;SUN Yat-sen University;Guangzhou 510120;P.R.China
HONG Guo-bin1;2;WU Wei-ming1;CHEN Kai1;FENG Xiao-xin1;LIANG Bi-ling21.Department of Radiology;Fifth Affiliated Hospital;SUN Yat-sen University;Zhuhai 519000;P.R.China2.Department of Radiology;Second Affiliated Hospital;SUN Yat-sen University;Guangzhou 510120;P.R.China
..............page:1025-1027
Breast cancer Ki-67 variation after neoadjuvant chemotherapy in different time
MA Xiang-jun;HE Xiang-ping;WANG jie;GAO Hai-feng;GU Yi-qun;GAO Ya-jun Breast Center;Beijing Haidian Maternal and Child Health Hospital;Beijing 100080;P.R.China
MA Xiang-jun;HE Xiang-ping;WANG jie;GAO Hai-feng;GU Yi-qun;GAO Ya-jun Breast Center;Beijing Haidian Maternal and Child Health Hospital;Beijing 100080;P.R.China
..............page:976-978
Clinical analysis of axillary lymph node metastasis as first symptom of occult breast cancer
SONG Ying-jie1;XU Jing-wei2;WU Yun-fei1;JIN Feng1;FAN Tao11.Department of Breast Surgery;First Affiliated Hospital of China Medical University;Shenyang 110001;P.R.China2.Department of General Surgery;Second Affiliated Hospital of Jilin University;Changchun 130000;P.R.China
SONG Ying-jie1;XU Jing-wei2;WU Yun-fei1;JIN Feng1;FAN Tao11.Department of Breast Surgery;First Affiliated Hospital of China Medical University;Shenyang 110001;P.R.China2.Department of General Surgery;Second Affiliated Hospital of Jilin University;Changchun 130000;P.R.China
..............page:1013-1014
Association between the genetic variant in CHRNA3 promoter and lung cancer risk in passive smoking population
YANG Lei1;L Xiao-xiao2;LING Xiao-xuan1;SONG Jian-ling2;JI Wei-dong1;BIN Xiao-nong1;LU·· Jia-chun11.Institute for Chemical Carcinogenesis;State Key Lab of Respiratory Disease;Guangzhou Medical College;Guangzhou 510182;P.R.Chang2.Guangzhou NO.6 Secondary School;Guangzhou 510300;P.R.China
YANG Lei1;L Xiao-xiao2;LING Xiao-xuan1;SONG Jian-ling2;JI Wei-dong1;BIN Xiao-nong1;LU·· Jia-chun11.Institute for Chemical Carcinogenesis;State Key Lab of Respiratory Disease;Guangzhou Medical College;Guangzhou 510182;P.R.Chang2.Guangzhou NO.6 Secondary School;Guangzhou 510300;P.R.China
..............page:972-975,990
Application of nano-scale drug vehicles in cancer therapy
ZHANG Shi-xin;LI Fang-qiu Institute of Medical Laboratory Science of PLA;Nanjing General Hospital of Nanjing Military Command; Nanjing 210002;P.R.China
ZHANG Shi-xin;LI Fang-qiu Institute of Medical Laboratory Science of PLA;Nanjing General Hospital of Nanjing Military Command; Nanjing 210002;P.R.China
..............page:1031-1034
Expression of VEGF-D and lymphangiogenesis in breast cancer and its significance
LI Guang-ming;DUAN Bai-yun Department of Oncology Ⅱ;Second Hospital of Ningbo;Ningbo 315010;P.R.China
LI Guang-ming;DUAN Bai-yun Department of Oncology Ⅱ;Second Hospital of Ningbo;Ningbo 315010;P.R.China
..............page:1004-1007
Effects of exogenous FHIT gene on malignant phenotype of human breast cancer cell line MDA-MB-436
WANG Xu-guang;CHEN Gen-yin;YANG Zhan;HE Hui-juan;WU Ping;WU Ying-jian Affiliated Hospital of Guangdong Medical College;Zhanjiang 524001;P.R.China
WANG Xu-guang;CHEN Gen-yin;YANG Zhan;HE Hui-juan;WU Ping;WU Ying-jian Affiliated Hospital of Guangdong Medical College;Zhanjiang 524001;P.R.China
..............page:979-981
Several issues of concern for radiotherapy after breast-conserving surgery
LI Jian-bin Department of Radiotherapy;Shandong Tumor Hospital;Jinan 250117;P.R.China
LI Jian-bin Department of Radiotherapy;Shandong Tumor Hospital;Jinan 250117;P.R.China
..............page:961-966
..............page:1044
Progress of PAR-2 in digestive cancer invasion and metastasis
LIU Cai-ju;XIE Li-qun Department of Gastroenterology;Affiliated Hospital;Medical College of Chinese People’s Armed Police Forces;Tianjin 300162;P.R.China
LIU Cai-ju;XIE Li-qun Department of Gastroenterology;Affiliated Hospital;Medical College of Chinese People’s Armed Police Forces;Tianjin 300162;P.R.China
..............page:1035-1038
..............page:1044
Expression of peptidylarginine deiminase 4 in tumors tissues
HOU Xiu-li1;CHANG Xiao-tian1;HUANG Hai-yan21.Shandong Medicinal Biotechnological Center;Shandong Academy of Medical Sciences;Key Laboratory for Biotech-Drugs of Ministry of Health;Key Laboratory for Modern Medicine and Technology of Shandong Province;Jinan 250062;P.R.China2.Department of Surgery;Tianqiao People’s Hospital of Jinan;Jinan 250031;P.R.China
HOU Xiu-li1;CHANG Xiao-tian1;HUANG Hai-yan21.Shandong Medicinal Biotechnological Center;Shandong Academy of Medical Sciences;Key Laboratory for Biotech-Drugs of Ministry of Health;Key Laboratory for Modern Medicine and Technology of Shandong Province;Jinan 250062;P.R.China2.Department of Surgery;Tianqiao People’s Hospital of Jinan;Jinan 250031;P.R.China
..............page:1008-1012
Expressions and clinical significance of BCRP and MRP1 in recurrent and metastastic invasive ductal breast cancer tissues
HAN Ye;LI Jian-yi;ZHANG Wen-hai;JIA Shi;ZHANG Yang Department of Breast Surgery;Shengjing Hospital;China Medical University;Shenyang 110004;P.R.China
HAN Ye;LI Jian-yi;ZHANG Wen-hai;JIA Shi;ZHANG Yang Department of Breast Surgery;Shengjing Hospital;China Medical University;Shenyang 110004;P.R.China
..............page:1000-1003,1007
..............page:1041-1042
Apoptosis of MDA-MB-453 breast cancer cells with HER-2 overexpression induced by VES and its relationship with expression of Fas and TGF-β1
JIANG Qiu-ying1;LI Li1;CHEN Xu-dong1;YANG Xiao-feng1;WU Lu-yan1;ZHAO Yu-ying2;XIN Tao1;CUI Feng11.Department of Oncology;Second Affiliated Hospital;Harbin Medical University;Harbin 150086;P.R.China2.Oncology Center;Forth Affiliated Hospital;Harbin Medical University;Harbin 150001;P.R.China
JIANG Qiu-ying1;LI Li1;CHEN Xu-dong1;YANG Xiao-feng1;WU Lu-yan1;ZHAO Yu-ying2;XIN Tao1;CUI Feng11.Department of Oncology;Second Affiliated Hospital;Harbin Medical University;Harbin 150086;P.R.China2.Oncology Center;Forth Affiliated Hospital;Harbin Medical University;Harbin 150001;P.R.China
..............page:982-985